Mark Baldry - Net Worth and Insider Trading

Mark Baldry Net Worth

The estimated net worth of Mark Baldry is at least $26,750 dollars as of 2024-11-05. Mark Baldry is the Chief Commercial Officer of X4 Pharmaceuticals Inc and owns about 48,509 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $26,750. Details can be seen in Mark Baldry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Baldry has not made any transactions after 2024-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Baldry

To

Mark Baldry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Baldry owns 3 companies in total, including WAVE Life Sciences Ltd (WVE) , Amicus Therapeutics Inc (FOLD) , and X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Mark Baldry’s form 4 insider trades.

Insider Ownership Summary of Mark Baldry

Ticker Comapny Transaction Date Type of Owner
WVE WAVE Life Sciences Ltd 2019-08-05 Chief Commerical Officer
FOLD Amicus Therapeutics Inc 2015-06-01 VP Global Marketing
XFOR X4 Pharmaceuticals Inc 2024-10-07 Chief Commercial Officer

Mark Baldry Latest Holdings Summary

Mark Baldry currently owns a total of 1 stock. Mark Baldry owns 48,509 shares of X4 Pharmaceuticals Inc (XFOR) as of October 7, 2024, with a value of $26,750.

Latest Holdings of Mark Baldry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2024-10-07 48,509 0.55 26,750

Holding Weightings of Mark Baldry


Mark Baldry Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Baldry has made a total of 2 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 11,127 shares on October 7, 2024, which brought Mark Baldry around $6,454.

Insider Trading History of Mark Baldry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Baldry Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Baldry Ownership Network

Ownership Network List of Mark Baldry

No Data

Ownership Network Relation of Mark Baldry

Insider Network Chart

Mark Baldry Owned Company Details

What does WAVE Life Sciences Ltd do?

Who are the key executives at WAVE Life Sciences Ltd?

Mark Baldry is the Chief Commerical Officer of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include See Remarks Chris Francis , director & See Remarks Paul Bolno , and 10 percent owner Plc Glaxosmithkline .

WAVE Life Sciences Ltd (WVE) Insider Trades Summary

Over the past 18 months, Mark Baldry made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 69,838 shares made by Kyle Moran , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 364,822 shares of WAVE Life Sciences Ltd (WVE) in total and bought 2,791,930 shares, with a net purchase of 2,427,108 shares. During the past 18 months, 417,514 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,674,416 shares.

WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

WAVE Life Sciences Ltd Insider Transactions

No Available Data

Mark Baldry Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Baldry. You might contact Mark Baldry via mailing address: C/o Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury Nj 08512.